-

Innovaderm Research Appoints Ina Zschocke as New Executive Vice President, European Operations and Strategy

MONTREAL--(BUSINESS WIRE)--Innovaderm, a leading clinical research organization (CRO) specializing in dermatology and rheumatology, is pleased to announce the appointment of Ina Zschocke, as the new Executive Vice President, European Operations and Strategy. This strategic hire underscores Innovaderm’s commitment to expanding its ever-growing presence and capabilities in the European market.

Ina Zschocke, PhD, MDRA brings more than 20 years of clinical research expertise, particularly in dermatology, allergology, and aesthetics. In her previous role as head of Dermatology, Immunology, and Inflammatory Diseases, she developed strategies for conducting high-quality clinical trials for emerging biopharma clients. Before this, Ina held various academic research positions and founded SCIderm, an international dermatology CRO, which she successfully led for 15 years until its acquisition.

“I am excited to join Innovaderm and look forward to contributing to the company’s success in Europe,” said Ina Zschocke. “Innovaderm’s dedication to innovation and excellence in dermatology and rheumatology research aligns perfectly with my professional values and goals.”

With the addition of Ina Zschocke, Innovaderm aims to enhance its operational efficiency and client service in Europe. She will be responsible for overseeing all European operations and contributing to business growth efforts. Moreover, Innovaderm is thrilled to highlight its attention on rheumatology, further broadening its research capabilities and commitment to advancing medical knowledge and elaborating new therapies.

“We are thrilled to welcome Ina Zschocke to our team,” said Dr. Robert Bissonnette, CEO of Innovaderm. “Her extensive experience and proven track record in the industry make her an invaluable asset as we continue to expand our footprint in Europe and strengthen our focus on rheumatology.”

For more information about our resources please visit: https://innovaderm.com/full-service-dermatology-cro/

Innovaderm Research Inc.

Innovaderm Research Inc. is a specialized CRO with a dual focus on dermatology and rheumatology. We assist biopharmaceutical sponsors in initiating and completing clinical trials. With over 25 years of globally recognized expertise in dermatology and clinical operations, an extensive and continually expanding network of clinicians and sites, and a dedicated research clinic, Innovaderm offers a highly informed, focused, and comprehensive approach to addressing niche clinical needs in dermatology and rheumatology.

Contacts

For more information:
Valerie Coveney
Communications Specialist
Innovaderm Research Inc.
vcoveney@innovaderm.com

Innovaderm Research Inc.



Contacts

For more information:
Valerie Coveney
Communications Specialist
Innovaderm Research Inc.
vcoveney@innovaderm.com

More News From Innovaderm Research Inc.

Indero Named Best Employer by Mercer

MONTREAL--(BUSINESS WIRE)--Indero, a global CRO specializing in dermatology and rheumatology, has been honored by Mercer, recognizing its excellence as a Best Employer. Indero is proud of its long-term commitment to building a workplace culture defined by trust, fairness, and meaningful employee experiences and believes this distinction reflects its positive impact in 2025. The Best Employers in Canada – Powered by Mercer certification program recognizes organizations that consistently deliver...

Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression

MONTREAL--(BUSINESS WIRE)--Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical research. This innovative method leverages quantitative gene expression analysis to assess drug efficacy rapidly and cost effectively. Dr. Robert Bissonnette, Executive Chairman and Founder of Indero, who initiated and led the study, shared his excitement about the results: “Our g...

Indero Celebrates 25 Years and Looks to the Future of Clinical Research

MONTREAL--(BUSINESS WIRE)--Indero, the niche CRO formerly known as Innovaderm, is celebrating 25 years of advancing clinical research. From its roots as a dermatology site in Montreal, Indero has grown into a global organization with capabilities in more than 30 countries across 4 continents and has earned a reputation for delivering expert, efficient trials in dermatology and, more recently, rheumatology. Indero was founded as Innovaderm in 2000, starting as a clinical site and now a global CR...
Back to Newsroom